Related Experiment Videos
Ketanserin: a new hypotensive drug?
Journal of Cardiovascular Pharmacology
|January 1, 1985
Summary
Ketanserin shows a hypotensive effect in essential hypertension, potentially by reducing vascular resistance. Further research is needed to compare its efficacy and long-term impact against standard treatments.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
Background:
- Essential hypertension management requires effective therapeutic options.
- Ketanserin's potential role in chronic hypertension treatment has been explored.
Purpose of the Study:
- To discuss the use of ketanserin for chronic essential hypertension.
- To evaluate ketanserin's hypotensive effects and mechanisms.
Main Methods:
- Review of data presented at a symposium on ketanserin.
- Analysis of placebo-controlled trials and existing data.
Main Results:
- Ketanserin demonstrates a hypotensive effect, likely by reducing systemic vascular resistance.
- Subjective side effects are noted initially but may decrease with chronic use.
- No organ toxicity reported at therapeutic doses.
Conclusions:
- Ketanserin's efficacy requires comparison with standard antihypertensive drugs.
- Its mechanism involving serotonin and alpha inhibition needs further elucidation for chronic use.
- Potentially beneficial for elderly patients with hypertension and peripheral vascular disease.